These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 12499384)

  • 1. Isolation and characterization of androgen receptor mutant, AR(M749L), with hypersensitivity to 17-beta estradiol treatment.
    Thin TH; Wang L; Kim E; Collins LL; Basavappa R; Chang C
    J Biol Chem; 2003 Feb; 278(9):7699-708. PubMed ID: 12499384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional analysis of androgen receptor N-terminal and ligand binding domain interacting coregulators in prostate cancer.
    Yeh S; Sampson ER; Lee DK; Kim E; Hsu CL; Chen YL; Chang HC; Altuwaijri S; Huang KE; Chang C
    J Formos Med Assoc; 2000 Dec; 99(12):885-94. PubMed ID: 11155740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dehydroepiandrosterone activates mutant androgen receptors expressed in the androgen-dependent human prostate cancer xenograft CWR22 and LNCaP cells.
    Tan J; Sharief Y; Hamil KG; Gregory CW; Zang DY; Sar M; Gumerlock PH; deVere White RW; Pretlow TG; Harris SE; Wilson EM; Mohler JL; French FS
    Mol Endocrinol; 1997 Apr; 11(4):450-9. PubMed ID: 9092797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in the helix 3 region of the androgen receptor abrogate ARA70 promotion of 17beta-estradiol-induced androgen receptor transactivation.
    Thin TH; Kim E; Yeh S; Sampson ER; Chen YT; Collins LL; Basavappa R; Chang C
    J Biol Chem; 2002 Sep; 277(39):36499-508. PubMed ID: 12068007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ligand- and coactivator-mediated transactivation function (AF2) of the androgen receptor ligand-binding domain is inhibited by the cognate hinge region.
    Wang Q; Lu J; Yong EL
    J Biol Chem; 2001 Mar; 276(10):7493-9. PubMed ID: 11102454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional in vivo interaction between the amino-terminal, transactivation domain and the ligand binding domain of the androgen receptor.
    Doesburg P; Kuil CW; Berrevoets CA; Steketee K; Faber PW; Mulder E; Brinkmann AO; Trapman J
    Biochemistry; 1997 Feb; 36(5):1052-64. PubMed ID: 9033395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human androgen receptor gene ligand-binding-domain mutations leading to disrupted interaction between the N- and C-terminal domains.
    Jääskeläinen J; Deeb A; Schwabe JW; Mongan NP; Martin H; Hughes IA
    J Mol Endocrinol; 2006 Apr; 36(2):361-8. PubMed ID: 16595706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A dominant-negative mutant of androgen receptor coregulator ARA54 inhibits androgen receptor-mediated prostate cancer growth.
    Miyamoto H; Rahman M; Takatera H; Kang HY; Yeh S; Chang HC; Nishimura K; Fujimoto N; Chang C
    J Biol Chem; 2002 Feb; 277(7):4609-17. PubMed ID: 11673464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and characterization of androgen receptor associated coregulators in prostate cancer cells.
    Sampson ER; Yeh SY; Chang HC; Tsai MY; Wang X; Ting HJ; Chang C
    J Biol Regul Homeost Agents; 2001; 15(2):123-9. PubMed ID: 11501969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations at the boundary of the hinge and ligand binding domain of the androgen receptor confer increased transactivation function.
    Buchanan G; Yang M; Harris JM; Nahm HS; Han G; Moore N; Bentel JM; Matusik RJ; Horsfall DJ; Marshall VR; Greenberg NM; Tilley WD
    Mol Endocrinol; 2001 Jan; 15(1):46-56. PubMed ID: 11145738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A naturally occurring mutation in the human androgen receptor of a subject with complete androgen insensitivity confers binding and transactivation by estradiol.
    Bonagura TW; Deng M; Brown TR
    Mol Cell Endocrinol; 2007 Jan; 263(1-2):79-89. PubMed ID: 17011702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Androgen antagonistic effect of estramustine phosphate (EMP) metabolites on wild-type and mutated androgen receptor.
    Wang LG; Liu XM; Kreis W; Budman DR
    Biochem Pharmacol; 1998 May; 55(9):1427-33. PubMed ID: 10076535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequences in the ligand-binding domains of the human androgen and progesterone receptors which determine their distinct ligand identities.
    Vivat V; Gofflo D; Garcia T; Wurtz JM; Bourguet W; Philibert D; Gronemeyer H
    J Mol Endocrinol; 1997 Apr; 18(2):147-60. PubMed ID: 9134501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Partial androgen insensitivity and correlations with the predicted three dimensional structure of the androgen receptor ligand-binding domain.
    Yong EL; Tut TG; Ghadessy FJ; Prins G; Ratnam SS
    Mol Cell Endocrinol; 1998 Feb; 137(1):41-50. PubMed ID: 9607727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation and characterization of the androgen receptor mutants with divergent transcriptional activity in response to hydroxyflutamide.
    Wang C; Young WJ; Chang C
    Endocrine; 2000 Feb; 12(1):69-76. PubMed ID: 10855693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human androgen receptor mutation disrupts ternary interactions between ligand, receptor domains, and the coactivator TIF2 (transcription intermediary factor 2).
    Lim J; Ghadessy FJ; Abdullah AA; Pinsky L; Trifiro M; Yong EL
    Mol Endocrinol; 2000 Aug; 14(8):1187-97. PubMed ID: 10935543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteasome activity is required for androgen receptor transcriptional activity via regulation of androgen receptor nuclear translocation and interaction with coregulators in prostate cancer cells.
    Lin HK; Altuwaijri S; Lin WJ; Kan PY; Collins LL; Chang C
    J Biol Chem; 2002 Sep; 277(39):36570-6. PubMed ID: 12119296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Supervillin associates with androgen receptor and modulates its transcriptional activity.
    Ting HJ; Yeh S; Nishimura K; Chang C
    Proc Natl Acad Sci U S A; 2002 Jan; 99(2):661-6. PubMed ID: 11792840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidermal growth factor increases coactivation of the androgen receptor in recurrent prostate cancer.
    Gregory CW; Fei X; Ponguta LA; He B; Bill HM; French FS; Wilson EM
    J Biol Chem; 2004 Feb; 279(8):7119-30. PubMed ID: 14662770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of androgen receptor transactivation by FoxH1. A newly identified androgen receptor corepressor.
    Chen G; Nomura M; Morinaga H; Matsubara E; Okabe T; Goto K; Yanase T; Zheng H; Lu J; Nawata H
    J Biol Chem; 2005 Oct; 280(43):36355-63. PubMed ID: 16120611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.